Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 7, 2024; 30(9): 1018-1042
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1018
Published online Mar 7, 2024. doi: 10.3748/wjg.v30.i9.1018
Grade | Wording | Criteria |
Strong | Shall, should, is recommended. Shall not, should not, is not recommended | Evidence, consistency of studies, risk-benefit ratio, patient preferences, ethical obligations, feasibility |
Weak or open | Can, may, is suggested. May not, is not suggested |
- Citation: Dar FS, Abbas Z, Ahmed I, Atique M, Aujla UI, Azeemuddin M, Aziz Z, Bhatti ABH, Bangash TA, Butt AS, Butt OT, Dogar AW, Farooqi JI, Hanif F, Haider J, Haider S, Hassan SM, Jabbar AA, Khan AN, Khan MS, Khan MY, Latif A, Luck NH, Malik AK, Rashid K, Rashid S, Salih M, Saeed A, Salamat A, Tayyab GUN, Yusuf A, Zia HH, Naveed A. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World J Gastroenterol 2024; 30(9): 1018-1042
- URL: https://www.wjgnet.com/1007-9327/full/v30/i9/1018.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i9.1018